eSense-Lab

About

eSense-Lab is a pharmatech company that is re-engineering the chemical composition of plants, starting with cannabis, in order to reformulate them for commercial applications. The company applies cutting-edge technologies and disruptive techniques to reverse engineer rare or lucrative plants, deconstructing the chemical profiles and using alternate natural products to then re-engineer and create the virtual plant. The result is a line of plant-based products with commercial and medicinal applications, viable for multiple markets and mass consumer consumption. eSense-Lab is an Israel-based life sciences research and development company listed on the ASX (ESE).

Facts

Public offerings (1)

Team (2)

News mentions (13)

1. Jul 23, 2020 — www.proactiveinvestors.com.au: Article
2. Jul 15, 2020 — www.proactiveinvestors.com.au: Article
3. Jul 7, 2020 — stockhead.com.au: Article
4. Jun 18, 2020 — www.businessnewsasia.com: Article
5. Jun 15, 2020 — finfeed.com: Article
6. May 28, 2020 — smallcaps.com.au: Article
7. Mar 6, 2020 — themarketherald.com.au: Article
8. Jul 2, 2019 — smallcaps.com.au: Article
9. Feb 7, 2019 — smallcaps.com.au: Article
10. Oct 23, 2018 — www.proactiveinvestors.co.uk: Article
11. Feb 15, 2017 — www.proactiveinvestors.com.au: Article
12. Feb 14, 2017 — www.businessnews.com.au: Article
13. Jan 24, 2017 — www.iposociety.com.au: Article